Actual Medicinal Product (AMP) Oruvail 200 modified-release capsules (CST Pharma Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light and moisture. Store in airtight container.

Provenance

This compatibility recommendation is derived from Oruvail 200 modified-release capsules (Sanofi).

Generic
Ketoprofen
Formulation
Ketoprofen 200mg modified-release capsules
  • Ketoprofen
    • Ketoprofen 200mg modified-release capsules
      • Oruvail 200 modified-release capsules (CST Pharma Ltd)

Alternative Suppliers (25)